ALPS Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.5M | Buy |
153,131
+4,463
| +3% | +$462K | 0.07% | 156 |
|
|
2026
Q1 | $14.4M | Sell |
148,668
-5,722
| -4% | -$587K | 0.07% | 157 |
|
|
2025
Q4 | $16.4M | Sell |
154,390
-8,960
| -5% | -$1.04M | 0.1% | 144 |
|
|
2025
Q3 | $20.7M | Sell |
163,350
-35,765
| -18% | -$4.26M | 0.12% | 117 |
|
|
2025
Q2 | $24.4M | Sell |
199,115
-1,347
| -0.7% | -$154K | 0.14% | 77 |
|
|
2025
Q1 | $20.3M | Buy |
200,462
+17,832
| +10% | +$1.74M | 0.12% | 113 |
|
|
2024
Q4 | $16.9M | Buy |
182,630
+27,817
| +18% | +$2.73M | 0.11% | 127 |
|
|
2024
Q3 | $15M | Buy |
154,813
+10,530
| +7% | +$946K | 0.1% | 127 |
|
|
2024
Q2 | $12.4M | Buy |
144,283
+6,843
| +5% | +$574K | 0.09% | 127 |
|
|
2024
Q1 | $11.3M | Buy |
137,440
+20,740
| +18% | +$1.52M | 0.08% | 134 |
|
|
2023
Q4 | $7.79M | Buy |
116,700
+16,399
| +16% | +$1.06M | 0.06% | 167 |
|
|
2023
Q3 | $6.74M | Sell |
100,301
-12,287
| -11% | -$845K | 0.06% | 162 |
|
|
2023
Q2 | $7.62M | Buy |
112,588
+35,021
| +45% | +$2.19M | 0.07% | 159 |
|
|
2023
Q1 | $4.2M | Buy |
77,567
+8,555
| +12% | +$498K | 0.04% | 189 |
|
|
2022
Q4 | $4.13M | Buy |
69,012
+7,061
| +11% | +$384K | 0.04% | 192 |
|
|
2022
Q3 | $2.8M | Buy |
61,951
+6,444
| +12% | +$322K | 0.03% | 240 |
|
|
2022
Q2 | $2.48M | Buy |
+55,507
| New | +$2.85M | 0.02% | 275 |
|
|
2020
Q3 | – | Sell |
-4,538
| Closed | -$224K | – | 854 |
|
|
2020
Q2 | $224K | Sell |
4,538
-505
| -10% | -$27.3K | ﹤0.01% | 720 |
|
|
2020
Q1 | $257K | Buy |
+5,043
| New | +$291K | ﹤0.01% | 548 |
|
|
2019
Q1 | – | Sell |
-7,278
| Closed | -$357K | – | 919 |
|
|
2018
Q4 | $357K | Sell |
7,278
-295
| -4% | -$16.8K | ﹤0.01% | 689 |
|
|
2018
Q3 | $470K | Buy |
+7,573
| New | +$461K | ﹤0.01% | 773 |
|
|
2017
Q4 | – | Sell |
-25,673
| Closed | -$947K | – | 857 |
|
|
2017
Q3 | $947K | Buy |
25,673
+5,225
| +26% | +$186K | 0.01% | 250 |
|
|
2017
Q2 | $787K | Buy |
20,448
+3,125
| +18% | +$114K | 0.01% | 269 |
|
|
2017
Q1 | $590K | Sell |
17,323
-901
| -5% | -$29.6K | ﹤0.01% | 286 |
|
|
2016
Q4 | $598K | Buy |
18,224
+5,437
| +43% | +$176K | ﹤0.01% | 274 |
|
|
2016
Q3 | $413K | Sell |
12,787
-1,392
| -10% | -$45.1K | ﹤0.01% | 543 |
|
|
2016
Q2 | $438K | Sell |
14,179
-1,046
| -7% | -$32.7K | ﹤0.01% | 354 |
|
|
2016
Q1 | $456K | Buy |
+15,225
| New | +$420K | ﹤0.01% | 318 |
|
|
2014
Q1 | – | Sell |
-18,101
| Closed | -$448K | – | 613 |
|
|
2013
Q4 | $448K | Buy |
18,101
+8,799
| +95% | +$245K | ﹤0.01% | 480 |
|
|
2013
Q3 | $255K | Buy |
+9,302
| New | +$239K | ﹤0.01% | 335 |
|
Other funds holding EHC
CCM
RP
CAM
TCM
ALPS Advisors's EHC Position: Q2 2026 in Review
ALPS Advisors increased its Encompass Health (EHC) stake by 3% in Q2 2026, buying an estimated $462K and bringing the position to 153,131 shares worth $15.5M. The position accounts for 0.07% of the portfolio, ranked #156.
ALPS Advisors first reported a position in EHC in Q3 2013 and has held it in 30 quarters since. The position peaked at $24.4M in Q2 2025. 274 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- ALPS Advisors held 153,131 shares of Encompass Health worth $15.5M as of Q2 2026.
- ALPS Advisors bought 4,463 Encompass Health shares in Q2 2026, an estimated $462K.
- Encompass Health made up 0.07% of ALPS Advisors's portfolio in Q2 2026, its #156 holding.
- ALPS Advisors first reported a position in Encompass Health in Q3 2013 and has held it in 30 quarters since.
- ALPS Advisors's Encompass Health position peaked at $24.4M in Q2 2025.
- 274 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.